Literature DB >> 20858623

Hyperuricaemia and gout: state of the art and future perspectives.

Nicola Dalbeth1, Alexander So.   

Abstract

Major progress has been made in the past decade in understanding the pathogenesis and treatment of gout. These advances include identification of the genetic and environmental risk factors for gout, recognition that gout is an important risk factor for cardiovascular disease, elucidation of the pathways regulating the acute gout attack and the development of novel therapeutic agents to treat both the acute and chronic phases of the disease. This review summarises these advances and highlights the research agenda for the next decade.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20858623     DOI： 10.1136/ard.2010.136218

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


  9 in total

Review 1.  Difficult-to-treat gouty arthritis: a disease warranting better management.

Authors:  Naomi Schlesinger
Journal:  Drugs       Date:  2011-07-30       Impact factor: 9.546

Review 2.  Imaging as an Outcome Measure in Gout Studies: Report from the OMERACT Gout Working Group.

Authors:  Rebecca Grainger; Nicola Dalbeth; Helen Keen; Laura Durcan; N Lawrence Edwards; Fernando Perez-Ruiz; Cesar Diaz-Torne; Jasvinder A Singh; Dinesh Khanna; Lee S Simon; William J Taylor
Journal:  J Rheumatol       Date:  2015-02-01       Impact factor: 4.666

3.  Relationship between hyperuricemia and dietary risk factors in Chinese adults: a cross-sectional study.

Authors:  Xue Li; Peige Song; Junping Li; Peiyu Wang; Guowei Li
Journal:  Rheumatol Int       Date:  2015-07-05       Impact factor: 2.631

4.  Allopurinol use in a New Zealand population: prevalence and adherence.

Authors:  Simon Horsburgh; Pauline Norris; Gordon Becket; Bruce Arroll; Peter Crampton; Jacqueline Cumming; Shirley Keown; Peter Herbison
Journal:  Rheumatol Int       Date:  2014-01-04       Impact factor: 2.631

5.  Mortality due to coronary heart disease and kidney disease among middle-aged and elderly men and women with gout in the Singapore Chinese Health Study.

Authors:  Gim Gee Teng; Li-Wei Ang; Kenneth G Saag; Mimi C Yu; Jian-Min Yuan; Woon-Puay Koh
Journal:  Ann Rheum Dis       Date:  2011-12-15       Impact factor: 19.103

6.  A Randomized, Double-Blind, Non-Inferiority Study of Febuxostat Versus Allopurinol in Hyperuricemic Chinese Subjects With or Without Gout.

Authors:  Fengchun Zhang; Zhichun Liu; Lindi Jiang; Hao Zhang; Dongbao Zhao; Yang Li; Hejian Zou; Xiaoyue Wang; Xiangpei Li; Bingyin Shi; Jianhua Xu; Hongjie Yang; Shaoxian Hu; Shen Qu
Journal:  Rheumatol Ther       Date:  2019-09-17

Review 7.  The pathophysiology of hyperuricaemia and its possible relationship to cardiovascular disease, morbidity and mortality.

Authors:  David Gustafsson; Robert Unwin
Journal:  BMC Nephrol       Date:  2013-07-29       Impact factor: 2.388

8.  Synergistic Uric Acid-Lowering Effects of the Combination of Chrysanthemum indicum Linne Flower and Cinnamomum cassia (L.) J. Persl Bark Extracts.

Authors:  Young-Sil Lee; Eunjung Son; Seung-Hyung Kim; Yun Mi Lee; Ohn Soon Kim; Dong-Seon Kim
Journal:  Evid Based Complement Alternat Med       Date:  2017-07-09       Impact factor: 2.629

9.  Combined Phyllostachys pubescens and Scutellaria baicalensis Prevent High-Fat Diet-Induced Obesity via Upregulating Thermogenesis and Energy Expenditure by UCP1 in Male C57BL/6J Mice.

Authors:  Yoon-Young Sung; Seung-Hyung Kim; Dong-Seon Kim
Journal:  Nutrients       Date:  2022-01-19       Impact factor: 5.717
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.